Active Ingredient(s):Cabotegravir Sodium FDA Approved: * January 21, 2021 Pharm Company: *VIIV HLTHCARE Category:HIV / AIDS
Cabotegravir, sold under the brand name Vocabria among others, is a antiretroviral medication used for the treatment of HIV/AIDS. It is available in the form of tablets and as an intramuscular injection, as well as in an injectable combination with rilpivirine under the brand name Cabenuva.
It is an integrase inhibitor with a carbamoyl pyridone structure similar to that of dolutegravir.
In December 2021, the U.S. Food and Drug Administ...
* May have multiple approval dates, manufacturers, or labelers.